1-20 of 448
Sort by
News

Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia

Ruth Jessen Hickman, MD
Published: 2023
Abstract
December 2023
View News titled, Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia
News

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

Leah Lawrence
Published: 2023
Abstract
December 2023
View News titled, Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML
News

All-Oral Mezigdomide Combo Shows Early Efficacy in R/R MM

Leah Lawrence
Published: 2023
Abstract
December 2023
View News titled, All-Oral Mezigdomide Combo Shows Early Efficacy in R/R MM
News

MPN Linked to Lower Death and Cardiac Arrest, Higher Bleeding in Patients Hospitalized With AMI

Katie Robinson
Published: 2023
Abstract
Mid-November 2023
View News titled, MPN Linked to Lower Death and Cardiac Arrest, Higher Bleeding in Patients Hospitalized With AMI
News

Eligibility Criteria Can Limit Patient Access

Ruth Jessen Hickman, MD
Published: 2023
Abstract
Mid-November 2023
View News titled, Eligibility Criteria Can Limit Patient Access
News

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

Lara C. Pullen, PhD
Published: 2023
Abstract
November 2023
View News titled, Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease
News

Heavy Menstrual Bleeding Evaluations Should Consider Variations in Product Absorption

Thomas R. Collins
Published: 2023
Abstract
November 2023
View News titled, Heavy Menstrual Bleeding Evaluations Should Consider Variations in Product Absorption
News

Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

Thomas R. Collins
Published: 2023
Abstract
November 2023
View News titled, Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL
News

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study
News

New Strategy Boosts Anti-BCMA CAR T-Cell Activity for Patients with Multiple Myeloma

Anna Azvolinsky, PhD
Published: 2023
Abstract
October 2023
View News titled, New Strategy Boosts Anti-BCMA CAR T-Cell Activity for Patients with Multiple Myeloma
News

Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A
News

Investigational BCMA-Directed CAR T-Cell Therapy for R/R Multiple Myeloma Provides Deep Responses, Low Toxicity

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Investigational BCMA-Directed CAR T-Cell Therapy for R/R Multiple Myeloma Provides Deep Responses, Low Toxicity
News

Cilta-Cel Bests Standard Care in Early Lenalidomide-Refractory MM

Katie Robinson
Published: 2023
Abstract
September 2023
View News titled, Cilta-Cel Bests Standard Care in Early Lenalidomide-Refractory MM
News

Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development

Anna Azvolinsky, PhD
Published: 2023
Abstract
September 2023
View News titled, Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development
News

Second-Line Axi-Cel Delivers OS Benefit for R/R LBCL

Leah Lawrence
Published: 2023
Abstract
September 2023
View News titled, Second-Line Axi-Cel Delivers OS Benefit for R/R LBCL
News

Isa-Kd Prolongs PFS to Almost Three Years in Early Relapsed MM Follow-up Study

Katie Robinson
Published: 2023
Abstract
August 2023
View News titled, Isa-Kd Prolongs PFS to Almost Three Years in Early Relapsed MM Follow-up Study
News

Ruxolitinib Demonstrates Superior Benefits in PV Resistant or Intolerant to Hydroxycarbamide

Linda Kossoff
Published: 2023
Abstract
August 2023
View News titled, Ruxolitinib Demonstrates Superior Benefits in PV Resistant or Intolerant to Hydroxycarbamide
News

First-Line Subcutaneous Rituximab May Increase PFS in Low Tumor Burden FL

Katie Robinson
Published: 2023
Abstract
August 2023
View News titled, First-Line Subcutaneous Rituximab May Increase PFS in Low Tumor Burden FL
News

JAK2-Unmutated Erythrocytosis From Gliflozins Appears Benign

Thomas R. Collins
Published: 2023
Abstract
August 2023
View News titled, JAK2-Unmutated Erythrocytosis From Gliflozins Appears Benign
News

Bleeding Symptoms in Patients With Ehlers-Danlos Syndrome Range From Mild to Life-Threatening

Linda Kossoff
Published: 2023
Abstract
August 2023
View News titled, Bleeding Symptoms in Patients With Ehlers-Danlos Syndrome Range From Mild to Life-Threatening